Liquidators of biotech startup in talks over stake in drug firm

Liquidators of biotech startup in talks over stake in drug firm
Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)
Riley Kennedy
Liquidators of a collapsed animal-breeding startup are in talks about its stake in another drug development company.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise of $800,000 in 2016.However, it collapsed in June last year after failing to find enough commercial contracts for its pr...

More Primary Sector

Port of Tauranga ‘reluctantly’ doubles MetroPort rail fees
Primary Sector

Port of Tauranga ‘reluctantly’ doubles MetroPort rail fees

The port says it's working with KiwiRail on 'long-term arrangements'. 

BX Foods settles director disputes, posts $7.9m loss
Primary Sector

BX Foods settles director disputes, posts $7.9m loss

The Chinese-owned food company removed three executives, alleging fiduciary breaches.

Riley Kennedy 03 Jul 2025